trial
as of 2026-07-01A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia
NCTId NCT01952041
at a glance
— · Completed
Enrollment 149 (actual)
Sponsored by Dartmouth-Hitchcock Medical Center
Primary completion 2017-08-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
149 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2015-03-13
Primary completion
2017-08-07
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
Dartmouth-Hitchcock Medical CenterLead Sponsor
Investigators
1
Dror Ben-Zeev, PhDPrincipal Investigator
Sites
1 total
Glen Oaks, United States
Facts & assertions
4 sourced
Enrollment
149
Phase
NA
Primary Completion Date
2017-08-07
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person